GaMF1.39

• UNSPSC Description:

  GaMF1.39 is an antimycobacterial compound, targeting the F-ATP synthase subunit γ. GaMF1.39 displays enhanced anti-tuberculosis activity in combination with ETC inhibitors[1].

• Target Antigen:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/gamf1-39.html

• Solubility:

  10 mM in DMSO

• Smiles:

  ClC1=CC=C(C2=NC3=C(C=CC(NC4=NC(NCC)=CC(C)=N4)=C3)N2)C=C1

• Molecular Weight:

  378.86

• References & Citations:

  [1]Ragunathan P, et al. GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876. Microbiol Spectr. 2023;11(6):e0228223.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2568607-82-7